Lung Cancer Clinical Trials in Kansas City, MO

Lung Cancer Clinical Trials in Kansas City, MO

View the best 10 lung cancer medical studies in Kansas City, Missouri. Access promising new therapies by applying to a Kansas City-based Lung Cancer clinical trial.

Trials in Kansas City, Missouri

Here are the top 10 medical studies for lung cancer in Kansas City, Missouri

Image of Grady Health System in Atlanta, United States.

Durvalumab +2 More

PD-L1 Inhibitor

Recruiting1 awardPhase 1
This trial is testing two different radiation schedules with durvalumab to see which is better at treating NSCLC.
Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Berzosertib +3 More

Enzyme Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a combination of drugs to treat squamous cell non-small cell lung cancer. The drugs are given to see if they work better than just the chemotherapy drugs carboplatin and gemcitabine.
Image of Lewis and Faye Manderson Cancer Center in Tuscaloosa, United States.

Carboplatin +2 More

Alkylating agent

Recruiting1 awardPhase 2
This trial is comparing two ways of treating patients with stage III non-small cell lung cancer with chemotherapy and radiation. One group of patients will also receive metformin hydrochloride, a drug that may help to keep the tumors from coming back. It is not yet known if this combination of treatments is more effective than just chemotherapy and radiation alone.
Image of Highlands Oncology Group in Springdale, United States.

Atezolizumab

Checkpoint Inhibitor

Recruiting2 awardsPhase 3
This trial is testing a new cancer treatment against the current best treatment, to see if the new treatment is more effective in preventing the cancer from returning.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Alaska Oncology and Hematology, LLC. in Anchorage, United States.

Sacituzumab Govitecan-hziy (SG) +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a new combination therapy for advanced or metastatic non-small-cell lung cancer (NSCLC) that has not responded to other treatments. The primary objectives are to assess the objective response rate (ORR) and to determine the recommended Phase 2 dose (RP2D) of the new therapy.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Whole-Brain Radiation Therapy

Radiation

Recruiting1 awardPhase 2 & 3
This trial is studying whether whole-brain radiation therapy is more effective with or without hippocampal avoidance in treating patients with small cell lung cancer.
Image of Research Site in Chandler, United States.

Durvalumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new cancer treatment (durvalumab with SoC SBRT) against the current best treatment (placebo with SoC SBRT) for early stage non-small cell lung cancer.
Image of Los Angeles County-USC Medical Center in Los Angeles, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is studying osimertinib with or without bevacizumab for patients with EGFR positive non-small cell lung cancer that has spread to the brain.
Image of Yuma Regional Medical Center Cancer Center in Yuma, United States.

Encorafenib +1 More

Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new combination therapy for patients with a specific type of lung cancer. The trial will test how well the new therapy works and if it is safe.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.